LncRNA GAS5 regulates migration and epithelial-to-mesenchymal transition in lens epithelial cells via the miR-204-3p/TGFBR1 axis
- PMID: 34916611
- DOI: 10.1038/s41374-021-00713-3
LncRNA GAS5 regulates migration and epithelial-to-mesenchymal transition in lens epithelial cells via the miR-204-3p/TGFBR1 axis
Abstract
Diabetic cataract (DC) is a major ocular complication secondary to diabetes mellitus. The epithelial-mesenchymal transition (EMT) of lens epithelial cells (LECs) is an important event in DC progression. Long non-coding RNAs (lncRNAs) and microRNAs are involved in various biological processes and disorders. The aim of this study was to investigate the roles of lncRNA growth arrest-specific transcript 5 (GAS5) and microRNA-204-3p (miR-204-3p) deregulation in the pathogenic mechanism of high glucose (HG)-stimulated LECs. The results show that GAS5 was up-regulated, whereas miR-204-3p was down-regulated in anterior lens capsule tissues of DC patients and in HG-treated LECs compared to their controls, respectively. Functional experiments suggest that the lentivirus-mediated depletion of GAS5, as well as overexpression of miR-204-3p, suppressed migration and EMT in HG-treated LECs. Further mechanistic studies revealed that lncRNA GAS5/miR-204-3p/type 1 receptor of transforming growth factor-beta (TGFBR1) has a regulatory role in the process. Collectively, we demonstrated that dysregulation of GAS5 affects lens epithelial cell migration and EMT under HG conditions via the miR-204-3p/TGFBR1 axis. The current findings may provide new insights into the molecular mechanisms of DC development.
© 2021. The Author(s), under exclusive licence to United States and Canadian Academy of Pathology.
References
-
- De Bruyne S., et al. A potential role for fructosamine-3-kinase in cataract treatment. Int. J. Mol. Sci. 22, 3841 (2021).
-
- Peterson, S. R., Silva, P. A., Murtha, T. J. & Sun, J. K. Cataract surgery in patients with diabetes: management strategies. Semin. Ophthalmol. 33, 75–82 (2018). - PubMed
-
- Obrosova, I. G., Chung, S. S. & Kador, P. F. Diabetic cataracts: mechanisms and management. Diabetes Metab. Res. Rev. 26, 172–180 (2010). - PubMed
-
- Hashim, Z. & Zarina, S. Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract. Age (Dordr) 33, 377–384 (2011).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources